782 related articles for article (PubMed ID: 7612054)
1. In vivo and in vitro interaction of the novel selective histamine H1 receptor antagonist mizolastine with H1 receptors in the rodent.
Benavides J; Schoemaker H; Dana C; Claustre Y; Delahaye M; Prouteau M; Manoury P; Allen J; Scatton B; Langer SZ
Arzneimittelforschung; 1995 May; 45(5):551-8. PubMed ID: 7612054
[TBL] [Abstract][Full Text] [Related]
2. Anti-anaphylactic activity of the novel selective histamine H1 receptor antagonist mizolastine in the rodent.
Levrier J; Duval D; Prouteau M; Voltz C; Berry CN; Lloyd KG; Scatton B
Arzneimittelforschung; 1995 May; 45(5):559-68. PubMed ID: 7541995
[TBL] [Abstract][Full Text] [Related]
3. Absence of an effect of terfenadine on guinea pig brain histamine H1-receptors in vivo determined by receptor binding techniques.
Wiech NL; Martin JS
Arzneimittelforschung; 1982; 32(9a):1167-70. PubMed ID: 6817763
[TBL] [Abstract][Full Text] [Related]
4. Pharmacology of [3H]-pyrilamine binding and of the histamine-induced inositol phosphates generation, intracellular Ca2+ -mobilization and cytokine release from human corneal epithelial cells.
Sharif NA; Wiernas TK; Griffin BW; Davis TL
Br J Pharmacol; 1998 Nov; 125(6):1336-44. PubMed ID: 9863665
[TBL] [Abstract][Full Text] [Related]
5. Studies on the pharmacology of the novel histamine H3 receptor agonist Sch 50971.
Hey JA; Aslanian R; Bolser DC; Chapman RW; Egan RW; Rizzo CA; Shih NY; Fernandez X; McLeod RL; West R; Kreutner W
Arzneimittelforschung; 1998 Sep; 48(9):881-8. PubMed ID: 9793613
[TBL] [Abstract][Full Text] [Related]
6. [Non-sedative antihistaminics and binding to central and peripheral H1 histamine receptors].
Leysen JE; Gommeren W; Janssen PF; Sanz G; Gillardin JM; Schotte A; Janssen PA
Allerg Immunol (Paris); 1991 Feb; 23(2):51-7. PubMed ID: 1677249
[TBL] [Abstract][Full Text] [Related]
7. Action of ebrotidine, ranitidine and cimetidine on the specific binding to histamine H1- and H2-receptors.
Agut J; Sánchez JC; Sacristán A; Ortiz JA
Arzneimittelforschung; 1997 Apr; 47(4A):447-9. PubMed ID: 9205741
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo binding characteristics of a new long-acting histamine H1 antagonist, astemizole.
Laduron PM; Janssen PF; Gommeren W; Leysen JE
Mol Pharmacol; 1982 Mar; 21(2):294-300. PubMed ID: 6124876
[TBL] [Abstract][Full Text] [Related]
9. Anti-inflammatory properties of mizolastine after oral administration on arachidonic acid-induced cutaneous reaction in the rat.
Pichat P; Angel I; Arbilla S
Arzneimittelforschung; 1998 Feb; 48(2):173-8. PubMed ID: 9541729
[TBL] [Abstract][Full Text] [Related]
10. Comparative, general pharmacology of SDZ NKT 343, a novel, selective NK1 receptor antagonist.
Walpole CS; Brown MC; James IF; Campbell EA; McIntyre P; Docherty R; Ko S; Hedley L; Ewan S; Buchheit KH; Urban LA
Br J Pharmacol; 1998 May; 124(1):83-92. PubMed ID: 9630347
[TBL] [Abstract][Full Text] [Related]
11. Analysis of an H1 receptor-mediated, zinc-potentiated vasoconstrictor action of the histidyl dipeptide carnosine in rabbit saphenous vein.
O'Dowd A; Miller DJ
Br J Pharmacol; 1998 Nov; 125(6):1272-80. PubMed ID: 9863657
[TBL] [Abstract][Full Text] [Related]
12. [The effect of antihistaminic preparations on the binding of labelled mepyramine, ketanserin and quinuclidinyl benzilate in the rat brain].
Gankina EM; Porodenko NV; Kondratenko TI; Severin ES; Kaminka ME; Mashkovskiĭ MD
Eksp Klin Farmakol; 1993; 56(1):22-4. PubMed ID: 8100727
[TBL] [Abstract][Full Text] [Related]
13. N-ethylmaleimide-induced changes in agonist affinity for histamine H1-receptors in the guinea pig brain.
Yeramian E; Garbarg M; Schwartz JC
Mol Pharmacol; 1985 Aug; 28(2):155-62. PubMed ID: 4022000
[TBL] [Abstract][Full Text] [Related]
14. Emedastine: a potent, high affinity histamine H1-receptor-selective antagonist for ocular use: receptor binding and second messenger studies.
Sharif NA; Su SX; Yanni JM
J Ocul Pharmacol; 1994; 10(4):653-64. PubMed ID: 7714409
[TBL] [Abstract][Full Text] [Related]
15. Rupatadine, a new potent, orally active dual antagonist of histamine and platelet-activating factor (PAF).
Merlos M; Giral M; Balsa D; Ferrando R; Queralt M; Puigdemont A; García-Rafanell J; Forn J
J Pharmacol Exp Ther; 1997 Jan; 280(1):114-21. PubMed ID: 8996188
[TBL] [Abstract][Full Text] [Related]
16. Histamine receptors in the myenteric plexus-longitudinal muscle of the guinea-pig ileum: H1- and H2-receptor-mediated potentiation of the contractile response to electrical stimulation.
Zavecz JH; Yellin TO
J Pharmacol Exp Ther; 1982 Oct; 223(1):177-82. PubMed ID: 6126581
[TBL] [Abstract][Full Text] [Related]
17. Histamine-stimulated phosphoinositide hydrolysis in developing rat brain.
Claro E; García A; Picatoste F
Mol Pharmacol; 1987 Sep; 32(3):384-90. PubMed ID: 2823091
[TBL] [Abstract][Full Text] [Related]
18. Histamine H1-receptor antagonists inhibit nuclear factor-kappaB and activator protein-1 activities via H1-receptor-dependent and -independent mechanisms.
Roumestan C; Henriquet C; Gougat C; Michel A; Bichon F; Portet K; Jaffuel D; Mathieu M
Clin Exp Allergy; 2008 Jun; 38(6):947-56. PubMed ID: 18498541
[TBL] [Abstract][Full Text] [Related]
19. Preclinical pharmacology of desloratadine, a selective and nonsedating histamine H1 receptor antagonist. 1st communication: receptor selectivity, antihistaminic activity, and antiallergenic effects.
Kreutner W; Hey JA; Anthes J; Barnett A; Young S; Tozzi S
Arzneimittelforschung; 2000 Apr; 50(4):345-52. PubMed ID: 10800633
[TBL] [Abstract][Full Text] [Related]
20. Molecular properties of central and peripheral histamine H1 and H2 receptors.
Carman-Krzan M; Lipnik-Stangelj M
Pflugers Arch; 2000; 439(3 Suppl):R131-2. PubMed ID: 10653166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
